标题
Tackling SARS-CoV-2: proposed targets and repurposed drugs
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume -, Issue -, Pages -
出版商
Future Science Ltd
发表日期
2020-06-22
DOI
10.4155/fmc-2020-0147
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
- (2020) Xin Liu et al. Journal of Genetics and Genomics
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Coronavirus puts drug repurposing on the fast track
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Influenza Polymerase Inhibitors: Mechanisms of Action and Resistance
- (2020) Emi Takashita Cold Spring Harbor Perspectives in Medicine
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- SARS‐CoV‐2: What do we know so far?
- (2020) Pratik H. Khedkar et al. Acta Physiologica
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity
- (2020) Priyanka Saha et al. BIOSCIENCE REPORTS
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- IL-6: Relevance for immunopathology of SARS-CoV-2
- (2020) E.O. Gubernatorova et al. CYTOKINE & GROWTH FACTOR REVIEWS
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural products may interfere with SARS-CoV-2 attachment to the host cell
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
- (2020) Salman Ali Khan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
- (2020) Junmei Wang Journal of Chemical Information and Modeling
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human‐pathogenic coronavirus (SARS‐CoV‐2)
- (2020) Yair Cárdenas‐Conejo et al. JOURNAL OF MEDICAL VIROLOGY
- The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
- (2020) Jrhau Lung et al. JOURNAL OF MEDICAL VIROLOGY
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
- (2020) Andrew I Ritchie et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Insights from nanomedicine into chloroquine efficacy against COVID-19
- (2020) Tony Y. Hu et al. Nature Nanotechnology
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine and covid-19
- (2020) Neeraj Sinha et al. POSTGRADUATE MEDICAL JOURNAL
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
- (2020) Ashleigh Shannon et al. ANTIVIRAL RESEARCH
- The possible of immunotherapy for COVID-19: A systematic review
- (2020) Akram AminJafari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
- (2020) Muhammad Adnan Shereen et al. Journal of Advanced Research
- Broad-spectrum coronavirus antiviral drug discovery
- (2019) Allison L. Totura et al. Expert Opinion on Drug Discovery
- The Orai Ca 2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis
- (2019) Richard T. Waldron et al. JOURNAL OF PHYSIOLOGY-LONDON
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- GRP78: A cell's response to stress
- (2019) Ibrahim M. Ibrahim et al. LIFE SCIENCES
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
- (2019) Robert N. Kirchdoerfer et al. Nature Communications
- Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis
- (2019) Mounica Vallurupalli et al. BLOOD
- Antibodies to watch in 2020
- (2019) Hélène Kaplon et al. mAbs
- Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
- (2018) Jian Lei et al. ANTIVIRAL RESEARCH
- Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
- (2018) Min-Han Lin et al. ANTIVIRAL RESEARCH
- Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis
- (2018) Yvette N. Lamb et al. DRUGS
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- New insights and long-term safety of tocilizumab in rheumatoid arthritis
- (2018) Graeme Jones et al. Therapeutic Advances in Musculoskeletal Disease
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- STIM1 controls T cell–mediated immune regulation and inflammation in chronic infection
- (2015) Ludovic Desvignes et al. JOURNAL OF CLINICAL INVESTIGATION
- Continuous and Discontinuous RNA Synthesis in Coronaviruses
- (2015) Isabel Sola et al. Annual Review of Virology
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro
- (2014) Rui-Rui Wang et al. PLoS One
- A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
- (2013) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- Glucocorticosteroid in Treatment of Severe Pneumonia
- (2013) Felinda Ariani et al. MEDIATORS OF INFLAMMATION
- Macrolide Therapy in Respiratory Viral Infections
- (2012) Jin-Young Min et al. MEDIATORS OF INFLAMMATION
- Comparison of SARS and NL63 Papain-Like Protease Binding Sites and Binding Site Dynamics: Inhibitor Design Implications
- (2011) Rima Chaudhuri et al. JOURNAL OF MOLECULAR BIOLOGY
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
- (2009) D. F. Smee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interferon and cytokine responses to SARS-coronavirus infection
- (2008) Volker Thiel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mepolizumab
- (2008) &NA; Drugs in research & development
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started